unknown
Stage
4
Investors
About
Hemotune develops an extracorporeal blood‑purification platform called HemoSystem that uses magnetic nanoparticles to selectively remove previously inaccessible biomolecules from blood. The technology is intended initially for treatment of uncontrolled immune reactions such as septic shock and may be applicable to other indications.
Explore Hemotune's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.